{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:16:57Z","timestamp":1778721417611,"version":"3.51.4"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":51,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01-DK081166"],"award-info":[{"award-number":["R01-DK081166"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["F31-AI181452"],"award-info":[{"award-number":["F31-AI181452"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-70878-2","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T02:15:50Z","timestamp":1774318550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antigen-specific immunotherapy with a CD4+ T cell neoepitope restrains CD8+ T cell differentiation in murine pancreatic islet grafts"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9216-0375","authenticated-orcid":false,"given":"James E.","family":"DiLisio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Scott","family":"Beard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Neef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9556-0718","authenticated-orcid":false,"given":"Stephen D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet M.","family":"Wenzlau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc A.","family":"D\u2019Antonio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Braxton L.","family":"Jamison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelli S.","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8361-8655","authenticated-orcid":false,"given":"Rocky L.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tonya M.","family":"Brunetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9730-5174","authenticated-orcid":false,"given":"Laurent","family":"Gapin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5430-6254","authenticated-orcid":false,"given":"Kathryn","family":"Haskins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"70878_CR1","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00281-014-0438-4","volume":"36","author":"P In\u2019t Veld","year":"2014","unstructured":"In\u2019t Veld, P. Insulitis in human type 1 diabetes: a comparison between patients and animal models. Semin. Immunopathol. 36, 569\u2013579 (2014).","journal-title":"Semin. Immunopathol."},{"key":"70878_CR2","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1172\/JCI94549","volume":"127","author":"A Pugliese","year":"2017","unstructured":"Pugliese, A. Autoreactive T cells in type 1 diabetes. J. Clin. Invest. 127, 2881\u20132891 (2017).","journal-title":"J. Clin. Invest."},{"key":"70878_CR3","doi-asserted-by":"publisher","first-page":"6152","DOI":"10.1016\/j.cell.2024.09.004","volume":"187","author":"S Wang","year":"2024","unstructured":"Wang, S. et al. Transplantation of chemically induced pluripotent stem-cell-derived islets under abdominal anterior rectus sheath in a type 1 diabetes patient. Cell 187, 6152\u20136164.e6118 (2024).","journal-title":"Cell"},{"key":"70878_CR4","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1038\/s41587-023-02055-5","volume":"42","author":"B Keymeulen","year":"2024","unstructured":"Keymeulen, B. et al. Encapsulated stem cell-derived beta cells exert glucose control in patients with type 1 diabetes. Nat. Biotechnol. 42, 1507\u20131514 (2024).","journal-title":"Nat. Biotechnol."},{"key":"70878_CR5","doi-asserted-by":"publisher","unstructured":"Reichman, T. W. et al. Stem cell-derived, fully differentiated islets for Type 1 diabetes. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMoa2506549","DOI":"10.1056\/NEJMoa2506549"},{"key":"70878_CR6","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.stem.2024.02.001","volume":"31","author":"X Hu","year":"2024","unstructured":"Hu, X. et al. Hypoimmune islets achieve insulin independence after allogeneic transplantation in a fully immunocompetent non-human primate. Cell Stem Cell 31, 334\u2013340.e335 (2024).","journal-title":"Cell Stem Cell"},{"key":"70878_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0272-6386(00)70348-9","volume":"35","author":"AM de Mattos","year":"2000","unstructured":"de Mattos, A. M., Olyaei, A. J. & Bennett, W. M. Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. Am. J. Kidney Dis. 35, 333\u2013346 (2000).","journal-title":"Am. J. Kidney Dis."},{"key":"70878_CR8","doi-asserted-by":"publisher","first-page":"e1302","DOI":"10.1093\/cid\/ciaa1189","volume":"73","author":"MB Roberts","year":"2021","unstructured":"Roberts, M. B. & Fishman, J. A. Immunosuppressive Agents and Infectious Risk in Transplantation: Managing the \u201cNet State of Immunosuppression\u201d. Clin. Infect. Dis. 73, e1302\u2013e1317 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"70878_CR9","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.2165\/00003495-200767080-00006","volume":"67","author":"A Gutierrez-Dalmau","year":"2007","unstructured":"Gutierrez-Dalmau, A. & Campistol, J. M. Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review. Drugs 67, 1167\u20131198 (2007).","journal-title":"Drugs"},{"key":"70878_CR10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1046\/j.1365-2567.2001.01335.x","volume":"104","author":"M Peakman","year":"2001","unstructured":"Peakman, M. & Dayan, C. M. Antigen-specific immunotherapy for autoimmune disease: fighting fire with fire? Immunology 104, 361\u2013366 (2001).","journal-title":"Immunology"},{"key":"70878_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41584-024-01201-w","volume":"21","author":"JH Buckner","year":"2025","unstructured":"Buckner, J. H. Antigen-specific immunotherapies for autoimmune disease. Nat. Rev. Rheumatol. 21, 88\u201397 (2025).","journal-title":"Nat. Rev. Rheumatol."},{"key":"70878_CR12","doi-asserted-by":"publisher","first-page":"101541","DOI":"10.1016\/j.smim.2021.101541","volume":"56","author":"SE Est-Witte","year":"2021","unstructured":"Est-Witte, S. E., Livingston, N. K., Omotoso, M. O., Green, J. J. & Schneck, J. P. Nanoparticles for generating antigen-specific T cells for immunotherapy. Semin. Immunol. 56, 101541 (2021).","journal-title":"Semin. Immunol."},{"key":"70878_CR13","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/MED.0000000000000647","volume":"28","author":"FF Kreiner","year":"2021","unstructured":"Kreiner, F. F., von Scholten, B. J., Coppieters, K. & von Herrath, M. Current state of antigen-specific immunotherapy for type 1 diabetes. Curr. Opin. Endocrinol. Diab Obes. 28, 411\u2013418 (2021).","journal-title":"Curr. Opin. Endocrinol. Diab Obes."},{"key":"70878_CR14","doi-asserted-by":"publisher","first-page":"1258369","DOI":"10.3389\/fimmu.2024.1258369","volume":"15","author":"R Firdessa-Fite","year":"2024","unstructured":"Firdessa-Fite, R. et al. Soluble antigen arrays provide increased efficacy and safety over free peptides for tolerogenic immunotherapy. Front. Immunol. 15, 1258369 (2024).","journal-title":"Front. Immunol."},{"key":"70878_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36225-5","volume":"14","author":"JM Gammon","year":"2023","unstructured":"Gammon, J. M. et al. Engineering the lymph node environment promotes antigen-specific efficacy in type 1 diabetes and islet transplantation. Nat. Commun. 14, 681 (2023).","journal-title":"Nat. Commun."},{"key":"70878_CR16","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/nri3607","volume":"14","author":"IK Poon","year":"2014","unstructured":"Poon, I. K., Lucas, C. D., Rossi, A. G. & Ravichandran, K. S. Apoptotic cell clearance: basic biology and therapeutic potential. Nat. Rev. Immunol. 14, 166\u2013180 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"70878_CR17","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1084\/jem.191.3.411","volume":"191","author":"RM Steinman","year":"2000","unstructured":"Steinman, R. M., Turley, S., Mellman, I. & Inaba, K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 191, 411\u2013416 (2000).","journal-title":"J. Exp. Med."},{"key":"70878_CR18","doi-asserted-by":"publisher","first-page":"5341","DOI":"10.4049\/jimmunol.1302070","volume":"191","author":"DR Getts","year":"2013","unstructured":"Getts, D. R., McCarthy, D. P. & Miller, S. D. Exploiting apoptosis for therapeutic tolerance induction. J. Immunol. 191, 5341\u20135346 (2013).","journal-title":"J. Immunol."},{"key":"70878_CR19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jaut.2012.04.005","volume":"39","author":"S Prasad","year":"2012","unstructured":"Prasad, S., Kohm, A. P., McMahon, J. S., Luo, X. & Miller, S. D. Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading. J. Autoimmun. 39, 347\u2013353 (2012).","journal-title":"J. Autoimmun."},{"key":"70878_CR20","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1021\/nn405033r","volume":"8","author":"Z Hunter","year":"2014","unstructured":"Hunter, Z. et al. A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease. ACS Nano 8, 2148\u20132160 (2014).","journal-title":"ACS Nano"},{"key":"70878_CR21","doi-asserted-by":"publisher","first-page":"465","DOI":"10.4049\/jimmunol.2200208","volume":"209","author":"JR Podojil","year":"2022","unstructured":"Podojil, J. R. et al. Tolerogenic immune-modifying nanoparticles encapsulating multiple recombinant pancreatic beta cell proteins prevent onset and progression of Type 1 diabetes in nonobese diabetic mice. J. Immunol. 209, 465\u2013475 (2022).","journal-title":"J. Immunol."},{"key":"70878_CR22","doi-asserted-by":"publisher","first-page":"864403","DOI":"10.3389\/fimmu.2022.864403","volume":"13","author":"N Benne","year":"2022","unstructured":"Benne, N., Ter Braake, D., Stoppelenburg, A. J. & Broere, F. Nanoparticles for inducing antigen-specific T cell tolerance in autoimmune diseases. Front. Immunol. 13, 864403 (2022).","journal-title":"Front. Immunol."},{"key":"70878_CR23","doi-asserted-by":"publisher","first-page":"119432","DOI":"10.1016\/j.biomaterials.2019.119432","volume":"222","author":"E Saito","year":"2019","unstructured":"Saito, E. et al. Design of biodegradable nanoparticles to modulate phenotypes of antigen-presenting cells for antigen-specific treatment of autoimmune disease. Biomaterials 222, 119432 (2019).","journal-title":"Biomaterials"},{"key":"70878_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jaut.2005.09.009","volume":"25","author":"LS Wicker","year":"2005","unstructured":"Wicker, L. S. et al. Type 1 diabetes genes and pathways shared by humans and NOD mice. J. Autoimmun. 25, 29\u201333 (2005).","journal-title":"J. Autoimmun."},{"key":"70878_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/cei.12672","volume":"183","author":"LS Walker","year":"2016","unstructured":"Walker, L. S. & von Herrath, M. CD4 T cell differentiation in type 1 diabetes. Clin. Exp. Immunol. 183, 16\u201329 (2016).","journal-title":"Clin. Exp. Immunol."},{"key":"70878_CR26","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0065-2776(05)87004-X","volume":"87","author":"K Haskins","year":"2005","unstructured":"Haskins, K. Pathogenic T-cell clones in autoimmune diabetes: more lessons from the NOD mouse. Adv. Immunol. 87, 123\u2013162 (2005).","journal-title":"Adv. Immunol."},{"key":"70878_CR27","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1126\/science.aad2791","volume":"351","author":"T Delong","year":"2016","unstructured":"Delong, T. et al. Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion. Science 351, 711\u2013714 (2016).","journal-title":"Science"},{"key":"70878_CR28","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.2337\/db22-0303","volume":"71","author":"SA Crawford","year":"2022","unstructured":"Crawford, S. A. et al. Cathepsin D drives the formation of hybrid insulin peptides relevant to the pathogenesis of Type 1 Diabetes. Diabetes 71, 2793\u20132803 (2022).","journal-title":"Diabetes"},{"key":"70878_CR29","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.2337\/db18-0200","volume":"67","author":"RL Baker","year":"2018","unstructured":"Baker, R. L. et al. CD4 T cells reactive to hybrid insulin peptides are indicators of disease activity in the NOD mouse. Diabetes 67, 1836\u20131846 (2018).","journal-title":"Diabetes"},{"key":"70878_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.omtm.2016.12.002","volume":"4","author":"SR Dastagir","year":"2017","unstructured":"Dastagir, S. R. et al. Efficient presentation of multiple endogenous epitopes to both CD4(+) and CD8(+) diabetogenic T cells for tolerance. Mol. Ther. Methods Clin. Dev. 4, 27\u201338 (2017).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"70878_CR31","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4049\/jimmunol.1900127","volume":"203","author":"BL Jamison","year":"2019","unstructured":"Jamison, B. L. et al. Nanoparticles containing an Insulin-ChgA hybrid peptide protect from transfer of autoimmune diabetes by shifting the balance between effector T cells and regulatory T cells. J. Immunol. 203, 48\u201357 (2019).","journal-title":"J. Immunol."},{"key":"70878_CR32","doi-asserted-by":"publisher","first-page":"667870","DOI":"10.3389\/fimmu.2021.667870","volume":"12","author":"SI Mannering","year":"2021","unstructured":"Mannering, S. I., Rubin, A. F., Wang, R. & Bhattacharjee, P. Identifying New Hybrid Insulin Peptides (HIPs) in Type 1 Diabetes. Front. Immunol. 12, 667870 (2021).","journal-title":"Front. Immunol."},{"key":"70878_CR33","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1021\/acs.jproteome.8b00875","volume":"18","author":"TA Wiles","year":"2019","unstructured":"Wiles, T. A. et al. Identification of Hybrid Insulin Peptides (HIPs) in Mouse and Human Islets by Mass Spectrometry. J. Proteome Res. 18, 814\u2013825 (2019).","journal-title":"J. Proteome Res."},{"key":"70878_CR34","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.2337\/db19-0128","volume":"68","author":"RL Baker","year":"2019","unstructured":"Baker, R. L. et al. Hybrid insulin peptides are autoantigens in Type 1 Diabetes. Diabetes 68, 1830\u20131840 (2019).","journal-title":"Diabetes"},{"key":"70878_CR35","doi-asserted-by":"publisher","first-page":"933","DOI":"10.2337\/db24-0611","volume":"74","author":"AC Hohenstein","year":"2025","unstructured":"Hohenstein, A. C. et al. Novel T-cell reactivities to hybrid insulin peptides in islet autoantibody-positive at-risk individuals. Diabetes 74, 933\u2013942 (2025).","journal-title":"Diabetes"},{"key":"70878_CR36","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.2337\/db19-0620","volume":"69","author":"D Arribas-Layton","year":"2020","unstructured":"Arribas-Layton, D. et al. Hybrid insulin peptides are recognized by human t cells in the context of DRB1*04:01. Diabetes 69, 1492\u20131502 (2020).","journal-title":"Diabetes"},{"key":"70878_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25404-x","volume":"12","author":"MT Tran","year":"2021","unstructured":"Tran, M. T. et al. T cell receptor recognition of hybrid insulin peptides bound to HLA-DQ8. Nat. Commun. 12, 5110 (2021).","journal-title":"Nat. Commun."},{"key":"70878_CR38","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2337\/db23-0622","volume":"73","author":"A Callebaut","year":"2024","unstructured":"Callebaut, A. et al. An Insulin-Chromogranin a hybrid peptide activates DR11-restricted T cells in human Type 1 diabetes. Diabetes 73, 743\u2013750 (2024).","journal-title":"Diabetes"},{"key":"70878_CR39","doi-asserted-by":"publisher","unstructured":"Mitchell, A. M. et al. T-cell responses to hybrid insulin peptides prior to type 1 diabetes development. Proc. Natl. Acad Sci. USA 118, https:\/\/doi.org\/10.1073\/pnas.2019129118","DOI":"10.1073\/pnas.2019129118"},{"key":"70878_CR40","doi-asserted-by":"publisher","first-page":"pgae491","DOI":"10.1093\/pnasnexus\/pgae491","volume":"3","author":"P Bhattacharjee","year":"2024","unstructured":"Bhattacharjee, P. et al. Proinsulin C-peptide is a major source of HLA-DQ8 restricted hybrid insulin peptides recognized by human islet-infiltrating CD4(+) T cells. PNAS Nexus 3, pgae491 (2024).","journal-title":"PNAS Nexus"},{"key":"70878_CR41","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.3389\/fimmu.2017.02001","volume":"8","author":"G Espinosa-Carrasco","year":"2017","unstructured":"Espinosa-Carrasco, G. et al. CD4(+) T helper cells play a key role in maintaining diabetogenic CD8(+) T cell function in the pancreas. Front. Immunol. 8, 2001 (2017).","journal-title":"Front. Immunol."},{"key":"70878_CR42","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nri.2015.10","volume":"16","author":"BJ Laidlaw","year":"2016","unstructured":"Laidlaw, B. J., Craft, J. E. & Kaech, S. M. The multifaceted role of CD4(+) T cells in CD8(+) T cell memory. Nat. Rev. Immunol. 16, 102\u2013111 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"70878_CR43","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.bbrc.2009.04.134","volume":"384","author":"S Zhang","year":"2009","unstructured":"Zhang, S., Zhang, H. & Zhao, J. The role of CD4 T cell help for CD8 CTL activation. Biochem. Biophys. Res. Commun. 384, 405\u2013408 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"70878_CR44","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/ni1129","volume":"5","author":"CM Smith","year":"2004","unstructured":"Smith, C. M. et al. Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity. Nat. Immunol. 5, 1143\u20131148 (2004).","journal-title":"Nat. Immunol."},{"key":"70878_CR45","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41590-020-0633-5","volume":"21","author":"HA Abdelsamed","year":"2020","unstructured":"Abdelsamed, H. A. et al. Beta cell-specific CD8(+) T cells maintain stem cell memory-associated epigenetic programs during type 1 diabetes. Nat. Immunol. 21, 578\u2013587 (2020).","journal-title":"Nat. Immunol."},{"key":"70878_CR46","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41586-021-04248-x","volume":"602","author":"SV Gearty","year":"2022","unstructured":"Gearty, S. V. et al. An autoimmune stem-like CD8 T cell population drives type 1 diabetes. Nature 602, 156\u2013161 (2022).","journal-title":"Nature"},{"key":"70878_CR47","doi-asserted-by":"publisher","unstructured":"Zakharov, P. N., Hu, H., Wan, X. & Unanue, E. R. Single-cell RNA sequencing of murine islets shows high cellular complexity at all stages of autoimmune diabetes. J. Exp. Med. 217. https:\/\/doi.org\/10.1084\/jem.20192362","DOI":"10.1084\/jem.20192362"},{"key":"70878_CR48","doi-asserted-by":"publisher","unstructured":"Kasmani, M. Y. et al. Autoreactive CD8 T cells in NOD mice exhibit phenotypic heterogeneity but restricted TCR gene usage. Life Sci. Alliance 5. https:\/\/doi.org\/10.26508\/lsa.202201503","DOI":"10.26508\/lsa.202201503"},{"key":"70878_CR49","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/s41590-022-01210-5","volume":"23","author":"S Grebinoski","year":"2022","unstructured":"Grebinoski, S. et al. Autoreactive CD8(+) T cells are restrained by an exhaustion-like program that is maintained by LAG3. Nat. Immunol. 23, 868\u2013877 (2022).","journal-title":"Nat. Immunol."},{"key":"70878_CR50","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1172\/JCI126595","volume":"130","author":"AE Wiedeman","year":"2020","unstructured":"Wiedeman, A. E. et al. Autoreactive CD8+ T cell exhaustion distinguishes subjects with slow type 1 diabetes progression. J. Clin. Invest. 130, 480\u2013490 (2020).","journal-title":"J. Clin. Invest."},{"key":"70878_CR51","doi-asserted-by":"publisher","first-page":"e2315419121","DOI":"10.1073\/pnas.2315419121","volume":"121","author":"C Selck","year":"2024","unstructured":"Selck, C. et al. Extraislet expression of islet antigen boosts T cell exhaustion to partially prevent autoimmune diabetes. Proc. Natl. Acad. Sci. USA 121, e2315419121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70878_CR52","doi-asserted-by":"publisher","first-page":"5813","DOI":"10.4049\/jimmunol.161.11.5813","volume":"161","author":"MP Wise","year":"1998","unstructured":"Wise, M. P., Bemelman, F., Cobbold, S. P. & Waldmann, H. Linked suppression of skin graft rejection can operate through indirect recognition. J. Immunol. 161, 5813\u20135816 (1998).","journal-title":"J. Immunol."},{"key":"70878_CR53","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1159\/000024046","volume":"118","author":"GF Hoyne","year":"1999","unstructured":"Hoyne, G. F., Dallman, M. J. & Lamb, J. R. Linked suppression in peripheral T cell tolerance to the house dust mite-derived allergen Der p 1. Int. Arch. Allergy Immunol. 118, 122\u2013124 (1999).","journal-title":"Int. Arch. Allergy Immunol."},{"key":"70878_CR54","doi-asserted-by":"publisher","first-page":"6116","DOI":"10.1073\/pnas.0401582101","volume":"101","author":"BJ Marsland","year":"2004","unstructured":"Marsland, B. J. et al. Bystander suppression of allergic airway inflammation by lung resident memory CD8+ T cells. Proc. Natl. Acad. Sci. USA 101, 6116\u20136121 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70878_CR55","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1007\/s00018-011-0907-z","volume":"69","author":"DM Gravano","year":"2012","unstructured":"Gravano, D. M. & Vignali, D. A. The battle against immunopathology: infectious tolerance mediated by regulatory T cells. Cell Mol. Life Sci. 69, 1997\u20132008 (2012).","journal-title":"Cell Mol. Life Sci."},{"key":"70878_CR56","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2337\/db20-1170","volume":"71","author":"BL Jamison","year":"2022","unstructured":"Jamison, B. L. et al. Tolerogenic delivery of a hybrid insulin peptide markedly prolongs islet graft survival in the NOD mouse. Diabetes 71, 483\u2013496 (2022).","journal-title":"Diabetes"},{"key":"70878_CR57","doi-asserted-by":"publisher","unstructured":"Neef, T. et al. Tolerance Induced by Antigen-Loaded PLG Nanoparticles Affects the Phenotype and Trafficking of Transgenic CD4(+) and CD8(+) T Cells. Cells 10. https:\/\/doi.org\/10.3390\/cells10123445","DOI":"10.3390\/cells10123445"},{"key":"70878_CR58","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1006\/jsre.1996.0322","volume":"64","author":"MD Stegall","year":"1996","unstructured":"Stegall, M. D., Loberman, Z., Ostrowska, A., Coulombe, M. & Gill, R. G. Autoimmune destruction of islet grafts in the NOD mouse is resistant to 15-deoxyspergualin but sensitive to anti-CD4 antibody. J. Surg. Res. 64, 156\u2013160 (1996).","journal-title":"J. Surg. Res."},{"key":"70878_CR59","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1006\/jaut.1993.1043","volume":"6","author":"DR Wegmann","year":"1993","unstructured":"Wegmann, D. R. et al. Establishment of islet-specific T-cell lines and clones from islet isografts placed in spontaneously diabetic NOD mice. J. Autoimmun. 6, 517\u2013527 (1993).","journal-title":"J. Autoimmun."},{"key":"70878_CR60","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1073\/pnas.88.2.527","volume":"88","author":"Y Wang","year":"1991","unstructured":"Wang, Y., Pontesilli, O., Gill, R. G., La Rosa, F. G. & Lafferty, K. J. The role of CD4+ and CD8+ T cells in the destruction of islet grafts by spontaneously diabetic mice. Proc. Natl. Acad. Sci. USA 88, 527\u2013531 (1991).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70878_CR61","doi-asserted-by":"publisher","first-page":"8384","DOI":"10.1073\/pnas.0932778100","volume":"100","author":"SM Lieberman","year":"2003","unstructured":"Lieberman, S. M. et al. Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes. Proc. Natl. Acad. Sci. USA 100, 8384\u20138388 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70878_CR62","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1097\/00007890-200205150-00011","volume":"73","author":"F Fu","year":"2002","unstructured":"Fu, F. et al. Long-term islet graft survival in streptozotocin- and autoimmune-induced diabetes models by immunosuppressive and potential insulinotropic agent FTY720. Transplantation 73, 1425\u20131430 (2002).","journal-title":"Transplantation"},{"key":"70878_CR63","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.2337\/diab.45.10.1350","volume":"45","author":"W Suarez-Pinzon","year":"1996","unstructured":"Suarez-Pinzon, W., Rajotte, R. V., Mosmann, T. R. & Rabinovitch, A. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction. Diabetes 45, 1350\u20131357 (1996).","journal-title":"Diabetes"},{"key":"70878_CR64","doi-asserted-by":"publisher","first-page":"1391504","DOI":"10.3389\/fimmu.2024.1391504","volume":"15","author":"Q Wang","year":"2024","unstructured":"Wang, Q. et al. Pancreatic islet transplantation: current advances and challenges. Front. Immunol. 15, 1391504 (2024).","journal-title":"Front. Immunol."},{"key":"70878_CR65","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell, C. et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol. 32, 381\u2013386 (2014).","journal-title":"Nat. Biotechnol."},{"key":"70878_CR66","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/mc.23362","volume":"61","author":"K Mohankumar","year":"2022","unstructured":"Mohankumar, K., Shrestha, R. & Safe, S. Nuclear receptor 4A1 (NR4A1) antagonists target paraspeckle component 1 (PSPC1) in cancer cells. Mol. Carcinog. 61, 73\u201384 (2022).","journal-title":"Mol. Carcinog."},{"key":"70878_CR67","doi-asserted-by":"publisher","first-page":"14001","DOI":"10.1074\/jbc.RA118.003099","volume":"293","author":"X You","year":"2018","unstructured":"You, X. et al. Transcriptional up-regulation of relaxin-3 by Nur77 attenuates beta-adrenergic agonist-induced apoptosis in cardiomyocytes. J. Biol. Chem. 293, 14001\u201314011 (2018).","journal-title":"J. Biol. Chem."},{"key":"70878_CR68","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1084\/jem.188.12.2301","volume":"188","author":"HS Azzam","year":"1998","unstructured":"Azzam, H. S. et al. CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J. Exp. Med. 188, 2301\u20132311 (1998).","journal-title":"J. Exp. Med."},{"key":"70878_CR69","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1084\/jem.192.12.1719","volume":"192","author":"M Fasso","year":"2000","unstructured":"Fasso, M. et al. T cell receptor (TCR)-mediated repertoire selection and loss of TCR vbeta diversity during the initiation of a CD4(+) T cell response in vivo. J. Exp. Med. 192, 1719\u20131730 (2000).","journal-title":"J. Exp. Med."},{"key":"70878_CR70","doi-asserted-by":"publisher","unstructured":"Campillo-Davo, D., Flumens, D. & Lion, E. The quest for the best: how TCR affinity, avidity, and functional avidity affect TCR-engineered T-cell antitumor responses. Cells 9. https:\/\/doi.org\/10.3390\/cells9071720","DOI":"10.3390\/cells9071720"},{"key":"70878_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/srep44661","volume":"7","author":"YF Fuchs","year":"2017","unstructured":"Fuchs, Y. F. et al. CD8(+) T cells specific for the islet autoantigen IGRP are restricted in their T cell receptor chain usage. Sci. Rep. 7, 44661 (2017).","journal-title":"Sci. Rep."},{"key":"70878_CR72","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/nature16962","volume":"530","author":"X Clemente-Casares","year":"2016","unstructured":"Clemente-Casares, X. et al. Expanding antigen-specific regulatory networks to treat autoimmunity. Nature 530, 434\u2013440 (2016).","journal-title":"Nature"},{"key":"70878_CR73","doi-asserted-by":"publisher","first-page":"1032575","DOI":"10.3389\/fimmu.2022.1032575","volume":"13","author":"RA Freeborn","year":"2022","unstructured":"Freeborn, R. A., Strubbe, S. & Roncarolo, M. G. Type 1 regulatory T cell-mediated tolerance in health and disease. Front. Immunol. 13, 1032575 (2022).","journal-title":"Front. Immunol."},{"key":"70878_CR74","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.immuni.2006.09.013","volume":"25","author":"M Kamanaka","year":"2006","unstructured":"Kamanaka, M. et al. Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse. Immunity 25, 941\u2013952 (2006).","journal-title":"Immunity"},{"key":"70878_CR75","doi-asserted-by":"publisher","first-page":"10443","DOI":"10.1073\/pnas.1705599114","volume":"114","author":"H Yu","year":"2017","unstructured":"Yu, H. et al. Intestinal type 1 regulatory T cells migrate to periphery to suppress diabetogenic T cells and prevent diabetes development. Proc. Natl. Acad. Sci. USA 114, 10443\u201310448 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70878_CR76","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.immuni.2018.01.006","volume":"48","author":"LK Smith","year":"2018","unstructured":"Smith, L. K. et al. Interleukin-10 Directly Inhibits CD8(+) T cell function by enhancing N-Glycan branching to decrease antigen sensitivity. Immunity 48, 299\u2013312.e295 (2018).","journal-title":"Immunity"},{"key":"70878_CR77","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.coi.2014.12.009","volume":"34","author":"SK Mittal","year":"2015","unstructured":"Mittal, S. K. & Roche, P. A. Suppression of antigen presentation by IL-10. Curr. Opin. Immunol. 34, 22\u201327 (2015).","journal-title":"Curr. Opin. Immunol."},{"key":"70878_CR78","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1182\/blood-2003-12-4302","volume":"104","author":"S Bhattacharyya","year":"2004","unstructured":"Bhattacharyya, S. et al. Immunoregulation of dendritic cells by IL-10 is mediated through suppression of the PI3K\/Akt pathway and of IkappaB kinase activity. Blood 104, 1100\u20131109 (2004).","journal-title":"Blood"},{"key":"70878_CR79","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41586-020-2611-3","volume":"584","author":"ST Ferris","year":"2020","unstructured":"Ferris, S. T. et al. cDC1 prime and are licensed by CD4(+) T cells to induce anti-tumour immunity. Nature 584, 624\u2013629 (2020).","journal-title":"Nature"},{"key":"70878_CR80","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1749-6632.1996.tb33504.x","volume":"793","author":"JN Peterson","year":"1996","unstructured":"Peterson, J. N. & Alpert, N. R. Molecular motor mechanics in the contracting heart. V1 versus V3 myosin heavy chain. Ann. N. Y Acad. Sci. 793, 54\u201363 (1996).","journal-title":"Ann. N. Y Acad. Sci."},{"key":"70878_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35615-5","volume":"14","author":"X Lei","year":"2023","unstructured":"Lei, X. et al. CD4(+) helper T cells endow cDC1 with cancer-impeding functions in the human tumor micro-environment. Nat. Commun. 14, 217 (2023).","journal-title":"Nat. Commun."},{"key":"70878_CR82","doi-asserted-by":"publisher","first-page":"592569","DOI":"10.3389\/fimmu.2020.592569","volume":"11","author":"J Busselaar","year":"2020","unstructured":"Busselaar, J., Tian, S., van Eenennaam, H. & Borst, J. Helpless priming sends CD8(+) T cells on the road to exhaustion. Front Immunol. 11, 592569 (2020).","journal-title":"Front Immunol."},{"key":"70878_CR83","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1126\/science.1229620","volume":"338","author":"MA Paley","year":"2012","unstructured":"Paley, M. A. et al. Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection. Science 338, 1220\u20131225 (2012).","journal-title":"Science"},{"key":"70878_CR84","doi-asserted-by":"crossref","unstructured":"Utzschneider, D. T. et al. T cell Factor 1-Expressing memory-like CD8(+) T cells sustain the immune response to chronic viral infections. Immunity 45, 415\u2013427 (2016).","DOI":"10.1016\/j.immuni.2016.07.021"},{"key":"70878_CR85","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1016\/j.immuni.2024.09.016","volume":"57","author":"N Aljobaily","year":"2024","unstructured":"Aljobaily, N. et al. Autoimmune CD4(+) T cells fine-tune TCF1 expression to maintain function and survive persistent antigen exposure during diabetes. Immunity 57, 2583\u20132596.e2586 (2024).","journal-title":"Immunity"},{"key":"70878_CR86","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1615\/CritRevImmunol.2014009988","volume":"34","author":"R Arakaki","year":"2014","unstructured":"Arakaki, R., Yamada, A., Kudo, Y., Hayashi, Y. & Ishimaru, N. Mechanism of activation-induced cell death of T cells and regulation of FasL expression. Crit. Rev. Immunol. 34, 301\u2013314 (2014).","journal-title":"Crit. Rev. Immunol."},{"key":"70878_CR87","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41590-024-02044-z","volume":"26","author":"S Singhaviranon","year":"2025","unstructured":"Singhaviranon, S., Dempsey, J. P., Hagymasi, A. T., Mandoiu, I. I. & Srivastava, P. K. Low-avidity T cells drive endogenous tumor immunity in mice and humans. Nat. Immunol. 26, 240\u2013251 (2025).","journal-title":"Nat. Immunol."},{"key":"70878_CR88","doi-asserted-by":"publisher","unstructured":"Sole, P. et al. A T follicular helper cell origin for T regulatory type 1 cells. Cell Mol. Immunol. https:\/\/doi.org\/10.1038\/s41423-023-00989-z","DOI":"10.1038\/s41423-023-00989-z"},{"key":"70878_CR89","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.4049\/jimmunol.1502481","volume":"197","author":"Y Tian","year":"2016","unstructured":"Tian, Y., Mollo, S. B., Harrington, L. E. & Zajac, A. J. IL-10 regulates memory T cell development and the balance between Th1 and follicular Th cell responses during an acute viral infection. J. Immunol. 197, 1308\u20131321 (2016).","journal-title":"J. Immunol."},{"key":"70878_CR90","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.4049\/jimmunol.146.10.3444","volume":"146","author":"DF Fiorentino","year":"1991","unstructured":"Fiorentino, D. F. et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146, 3444\u20133451 (1991).","journal-title":"J. Immunol."},{"key":"70878_CR91","doi-asserted-by":"publisher","first-page":"7761","DOI":"10.4049\/jimmunol.177.11.7761","volume":"177","author":"H Qin","year":"2006","unstructured":"Qin, H. et al. IL-10 inhibits lipopolysaccharide-induced CD40 gene expression through induction of suppressor of cytokine signaling-3. J. Immunol. 177, 7761\u20137771 (2006).","journal-title":"J. Immunol."},{"key":"70878_CR92","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.coi.2010.08.002","volume":"22","author":"AR Kendal","year":"2010","unstructured":"Kendal, A. R. & Waldmann, H. Infectious tolerance: therapeutic potential. Curr. Opin. Immunol. 22, 560\u2013565 (2010).","journal-title":"Curr. Opin. Immunol."},{"key":"70878_CR93","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1126\/science.8094901","volume":"259","author":"S Qin","year":"1993","unstructured":"Qin, S. et al. Infectious\u201d transplantation tolerance. Science 259, 974\u2013977 (1993).","journal-title":"Science"},{"key":"70878_CR94","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/S0952-7915(98)80217-3","volume":"10","author":"S Cobbold","year":"1998","unstructured":"Cobbold, S. & Waldmann, H. Infectious tolerance. Curr. Opin. Immunol. 10, 518\u2013524 (1998).","journal-title":"Curr. Opin. Immunol."},{"key":"70878_CR95","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41586-024-07752-y","volume":"632","author":"H Sultan","year":"2024","unstructured":"Sultan, H. et al. Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy. Nature 632, 182\u2013191 (2024).","journal-title":"Nature"},{"key":"70878_CR96","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/nprot.2006.61","volume":"1","author":"J Holst","year":"2006","unstructured":"Holst, J. et al. Generation of T-cell receptor retrogenic mice. Nat. Protoc. 1, 406\u2013417 (2006).","journal-title":"Nat. Protoc."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70878-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70878-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70878-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:06:33Z","timestamp":1778720793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70878-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["70878"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-70878-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SDM is a cofounder, member of the scientific advisory board, a paid consultant, grantee, and holds stock in Cour Pharmaceuticals Development Company; a paid consultant and member of the scientific advisory board of NextCure, Inc.; and a paid consultant for Takeda Pharmaceuticals International Co. No other authors reported conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4355"}}